Literature DB >> 9927434

Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells.

G J Schoenhals1, R M Krishna, A G Grandea, T Spies, P A Peterson, Y Yang, K Früh.   

Abstract

Presentation of antigen-derived peptides by major histocompatibility complex (MHC) class I molecules is dependent on an endoplasmic reticulum (ER) resident glycoprotein, tapasin, which mediates their interaction with the transporter associated with antigen processing (TAP). Independently of TAP, tapasin was required for the presentation of peptides targeted to the ER by signal sequences in MHC class I-transfected insect cells. Tapasin increased MHC class I peptide loading by retaining empty but not peptide-containing MHC class I molecules in the ER. Upon co-expression of TAP, this retention/release function of tapasin was sufficient to reconstitute MHC class I antigen presentation in insect cells, thus defining the minimal non-housekeeping functions required for MHC class I antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927434      PMCID: PMC1171167          DOI: 10.1093/emboj/18.3.743

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits.

Authors:  K Früh; Y Yang; D Arnold; J Chambers; L Wu; J B Waters; T Spies; P A Peterson
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

2.  Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Authors:  A Townsend; C Ohlén; J Bastin; H G Ljunggren; L Foster; K Kärre
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

3.  Assembly of MHC class I molecules analyzed in vitro.

Authors:  A Townsend; T Elliott; V Cerundolo; L Foster; B Barber; A Tse
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

4.  Differential transport requirements of HLA and H-2 class I glycoproteins.

Authors:  J Alexander; J A Payne; R Murray; J A Frelinger; P Cresswell
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance.

Authors:  M Andersson; S Pääbo; T Nilsson; P A Peterson
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

6.  Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells.

Authors:  M R Jackson; E S Song; Y Yang; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  T cell receptor alpha-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant.

Authors:  F R Carbone; S J Sterry; J Butler; S Rodda; M W Moore
Journal:  Int Immunol       Date:  1992-08       Impact factor: 4.823

8.  Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum.

Authors:  M R Jackson; T Nilsson; P A Peterson
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

9.  Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.

Authors:  F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.

Authors:  K Anderson; P Cresswell; M Gammon; J Hermes; A Williamson; H Zweerink
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

View more
  27 in total

1.  Direct peptide-regulatable interactions between MHC class I molecules and tapasin.

Authors:  Syed Monem Rizvi; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Characterization and phylogenetic analysis of a cnidarian LMP X-like cDNA.

Authors:  Larry J Dishaw; Manuel L Herrera; Charles H Bigger
Journal:  Immunogenetics       Date:  2006-03-22       Impact factor: 2.846

Review 3.  The convergent roles of tapasin and HLA-DM in antigen presentation.

Authors:  Scheherazade Sadegh-Nasseri; Mingnan Chen; Kedar Narayan; Marlene Bouvier
Journal:  Trends Immunol       Date:  2008-02-07       Impact factor: 16.687

Review 4.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

5.  Cloning and functional analyses of the mouse tapasin promoter.

Authors:  Felix Herrmann; John Trowsdale; Christoph Huber; Barbara Seliger
Journal:  Immunogenetics       Date:  2003-08-26       Impact factor: 2.846

Review 6.  Functional regulation of immunoproteasomes and transporter associated with antigen processing.

Authors:  L Y Hwang; P T Lieu; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 7.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

8.  Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules.

Authors:  Xiuju Lu; Daniel G Kavanagh; Ann B Hill
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 9.  What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules?

Authors:  Alan Belicha-Villanueva; Jennifer Blickwedehl; Sarah McEvoy; Michelle Golding; Sandra O Gollnick; Naveen Bangia
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

Review 10.  MHC class I assembly: out and about.

Authors:  Malini Raghavan; Natasha Del Cid; Syed Monem Rizvi; Larry Robert Peters
Journal:  Trends Immunol       Date:  2008-09       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.